10x Genomics, Inc.
TXG10x Genomics, Inc. is an American biotechnology company that designs and manufactures sequencing technologies for use in scientific research, with a focus on product development for single-cell and spatial omics.
Drugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 1 past
No catalysts found.
How TXG's past catalysts played out
No drugs found in this phase.
Frequently asked questions
When is 10x Genomics, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for 10x Genomics, Inc. (TXG) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track TXG biotech catalysts?→
Add TXG to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow 10x Genomics, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.